Loading clinical trials...
Loading clinical trials...
The aim of this pilot study is to examine whether metacognitive training can improve symptoms, wellbeing and functioning in individuals with attenuated psychotic symptoms. Metacognitive group training...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Vienna
NCT07226895 · Clinical High Risk for Psychosis (CHR)
NCT05968560 · Clinical High Risk for Psychosis (CHR)
NCT06640803 · Clinical High Risk for Psychosis, Ultra High Risk for Psychosis
NCT05509998 · First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR)
NCT07434973 · Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, and more
Department of Child and Adolescent Psychiatry
Vienna
Department of Psychiatry and Psychotherapy
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions